Australia said on Sunday it would list state-owned health insurer Medibank Private Ltd (MPL.AX) with a market capitalization of A$5.679 billion ($4.9 billion), exceeding the top end of a range indicated in its IPO filing a month earlier.
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
About 160 Chinese health workers arrived on Saturday in Liberia, where they are due to staff a new $41 million Ebola clinic that, unlike most other foreign interventions, is being built and fully run by Chinese personnel.
President Barack Obama's plan to extend private health coverage to the uninsured entered a new uncertain phase on Saturday as U.S. government-backed online insurance marketplaces opened their 2015 plans to millions of potential enrollees.
Indian generic drugmaker Aurobindo Pharma Ltd (ARBN.NS) said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.
The U.S. administration on Monday dramatically cut expectations for 2015 Obamacare enrollment, saying it aims to have a total of 9.1 million people enrolled in government-backed federal and state health insurance marketplaces next year.
The chief executive of Quest Diagnostics Inc (DGX.N) said his company will stick to its core business of diagnostic testing and is not interested in acquiring a contract research organization (CRO), despite such a planned move by rival diagnostics firm LabCorp (LH.N).
Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).
Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) on Monday said in a letter to Allergan Inc's (AGN.N) board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.
Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of tosedostat. CTI previously held rights to tosedostat in the Americas under a Licence Agreement with Chroma. Chroma no longer retains any ongoing rights or financial interest in tosedostat.
Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other public-health threats.
Australia's CSL Ltd (CSL.AX), the world's largest blood products company, said on Monday it had agreed to buy Novartis AG's (NOVN.VX) global influenza vaccine business for $275 million.
Salesforce Inc is betting big on healthcare, hiring key personnel and ramping up investment in hopes of replacing outmoded medical industry infrastructure and carving out a $1 billion annual business.
Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV [COUCKO.UL], Bloomberg reported, citing people familiar with the matter.